Tag: Dr A Wesley Burks

Paliforzia (AR101)

Results of Phase III Trial of Aimmune's Peanut OIT Therapy

After one year, 3/4 of patients ages 4-17 who received the therapy were able to consume a minimum of 300mg of peanut. Results for adults were less clear.